Telemedicine for treating mental health and substance use disorders: reflections since the pandemic

Neuropsychopharmacology. 2021 May;46(6):1068-1070. doi: 10.1038/s41386-021-00960-4. Epub 2021 Jan 21.

Authors

Alisa B Busch^{1

2

3}, Dawn E Sugarman^{4

5}, Lisa E Horvitz⁴, Shelly F Greenfield^{4

5}

Affiliations

¹ McLean Hospital, Belmont, MA, USA. abusch@mclean.harvard.edu.
² Department of Psychiatry, Harvard Medical School, Boston, MA, USA. abusch@mclean.harvard.edu.
³ Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. abusch@mclean.harvard.edu.
⁴ McLean Hospital, Belmont, MA, USA.
⁵ Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Humans
Mental Disorders* / epidemiology
Mental Disorders* / therapy
Mental Health
Pandemics
Substance-Related Disorders* / epidemiology
Substance-Related Disorders* / therapy
Telemedicine*

Grants and funding